Lead Researcher: Dr Mustafa Khasraw
Institution: NHMRC Clinical Trials Centre, the University of Sydney
Funding: $359,460
Funding Duration: 2016 - 2018
The Research
A trial to investigate if the addition of the drug Veliparib to chemotherapy improves outcomes for glioblastoma patients.
share
.svg)
